Bernhard Witzenbichler

Author

Cardiovascular Research Foundation ORCID

Also Known As

B Witzenbichler, B. Witzenbichler, BERNHARD WITZENBICHLER, Bernhard Witzenbichler, Giuseppe Musumeci, Marcus L. Williams, Michael Maeng, Ping Zhang, Witzenbichler Bernhard, Witzenbichler, Bernhard

444

Publications

30.2K

Citations

H-Index

Concepts

All Affiliations

Cardiovascular Research Foundation Columbia University Irving Medical Center Helios Amper-Klinikum Dachau Icahn School of Medicine at Mount Sinai Charité - Universitätsmedizin Berlin

About

Bernhard Witzenbichler is an author at Cardiovascular Research Foundation specializing in medicine, cardiovascular disease, and cardiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	46	99	17.1K
2	Public Health	22	29	1.4K
3	Health Sciences	4	4	474
4	Engineering	2	2	188
5	Anatomy	1	1	10

Bernhard Witzenbichler

198

Publications

29.5K

Citations

H-Index

Page 1

	Year	Citations
Isolation of Putative Progenitor Endothelial Cells for Angiogenesis Takayuki Asahara, Toyoaki Murohara, Alison Sullivan, Science Regenerative MedicineActive AngiogenesisUtilitarian AngiogenesisAngiogenesisDevelopmental Biology	1997	8.7K
Bivalirudin during Primary PCI in Acute Myocardial Infarction Gregg W. Stone, Bernhard Witzenbichler, Giulio Guagliumi, New England Journal of Medicine	2008	1.8K
Ticagrelor with or without Aspirin in High-Risk Patients after PCI Roxana Mehran, Usman Baber, Samin K. Sharma, New England Journal of Medicine	2019	957
Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study Gregg W. Stone, Bernhard Witzenbichler, Giora Weisz, The Lancet ThrombosisPercutaneous Coronary InterventionCardiovascular DiseaseBlood PlateletCoronary Artery Disease	2013	842
Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes Stefanie Schüpke, Franz‐Josef Neumann, Maurizio Menichelli, New England Journal of Medicine	2019	756
Mouse model of angiogenesis. Thierry Couffinhal, David M. Silver, Lu Zheng, PubMed	1998	670
Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study Roxana Mehran, Usman Baber, Philippe Gabríel Steg, The Lancet ThrombosisPercutaneous Coronary InterventionCardiovascular DiseaseDual Antiplatelet TreatmentCoronary Artery Disease	2013	609
Coronary Thrombosis and Major Bleeding After PCI With Drug-Eluting Stents Usman Baber, Roxana Mehran, Gennaro Giustino, Journal of the American College of Cardiology ThrombosisPercutaneous Coronary InterventionCardiovascular DiseaseCoronary Artery DiseaseCoronary Thrombosis	2016	535
Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial Gregg W. Stone, Bernhard Witzenbichler, Giulio Guagliumi, The Lancet ThrombosisPercutaneous Coronary InterventionCardiovascular DiseasePaclitaxel-eluting StentsMyocardial Infarction	2011	447
Incidence, Predictors, and Impact of Post-Discharge Bleeding After Percutaneous Coronary Intervention Philippe Généreux, Gennaro Giustino, Bernhard Witzenbichler, Journal of the American College of Cardiology ThrombosisPercutaneous Coronary InterventionPost-discharge BleedingCardiovascular DiseaseCoronary Artery Disease	2015	442

Page 1